Quarterly cash SG&A baseline
Company: Core Scientific
The claim, verbatim
The company views cash SG&A in the low-$30 million range, roughly $30 million per quarter, as a reasonable quarterly baseline for modeling.
Source (primary)
Core Scientific Inc (CORZ) (Q3 2026) Earnings Call Highlights: Colocation Revenue Surges 60% as ... - Yahoo Finance UK (-, news_article)
View cached copy (2026-11-07)Live source ↗Archive.org ↗
Quote: “roughly $30 million per quarter in cash SG&A as the building blocks for modeling consolidated EBITDA”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific Inc (CORZ) (Q3 2026) Earnings Call Highlights: Colocation Revenue Surges 60% as ... - Yahoo Finance UK
Quote: “roughly $30 million per quarter in cash SG&A as the building blocks for modeling consolidated EBITDA”